Graf Akcie HQY (Healthequity Inc). Diskuze k akciím HQY. Aktuální informace HQY.

Základní informace o společnosti Healthequity Inc (Akcie HQY)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.38B
Hodnota podniku (EV) 5.33B
Tržby 740.825M
EBITDA 139.714M
Zisk 723.000k
Růst v tržbách Q/Q 7.42 %
Růst v tržbách Y/Y 2.27 %
P/E (Cena vůči ziskům) 6,315.00
Forward P/E 0.08
EV/Sales 7.19
EV/EBITDA 38.12
EV/EBIT 320.78
PEG 2.11
Price/Sales 7.27
P/FCF 49.46
Price/Book 3.90
Účetní hodnota na akcii 16.17
Hotovost na akcii 3.86
FCF vůči ceně 2.02 %
Počet zaměstnanců 3,020
Tržba na zaměstnance 245.306k
Profit margin 1.20 %
Operating margin 1.79 %
Gross margin 56.62 %
EBIT margin 2.24 %
EBITDA margin 18.86 %
EPS - Zisk na akcii 0.01
EPS - Kvartální růst -4.76 %
EPS - Očekávaný růst příští rok -9.76 %
Return on assets 0.02 %
Return on equity 0.04 %
ROIC 1.48 %
ROCE 0.56 %
Dluhy/Equity 0.97
Čistý dluh/EBITDA 15.48
Current ratio 4.65
Quick Ratio 4.65
Volatilita 3.51
Beta 1.10
RSI 44.07
Cílová cena analytiků 67
Známka akcie (dle analytiků) 1.57
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 83.509M
Procento shortovaných akcií 4.52 %
Short ratio 6.62 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie HQY

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$531.993$287.243$229.525$178.37$126.786$87.855$62.015$46.088
Cost Of Goods Sold$206.084$106.05$94.609$72.015$54.188$39.882$29.213$21.968
Gross Profit$325.909$181.193$134.916$106.355$72.598$47.973$32.802$24.12
Research And Development Expenses$77.576$35.057$27.385$22.375$16.832$10.501$7.142$4.229
SG&A Expenses$104.512$62.537$48.25$38.471$27.415$18.962$12.499$11.162
Other Operating Income Or Expenses$-32.111-------
Operating Expenses$454.987$209.573$175.107$137.158$100.643$70.982$50.491$38.996
Operating Income$77.006$77.67$54.418$41.212$26.143$16.873$11.524$7.092
Total Non-Operating Income/Expense$-33.851$-1.852$-2.229$-1.092$-0.589$-1.109$-6.15$-0.59
Pre-Tax Income$43.155$75.818$52.189$40.12$25.554$15.764$5.374$6.502
Income Taxes$3.491$1.919$4.827$13.744$8.941$5.598$4.141$-4.667
Income After Taxes$39.664$73.899$47.362$26.376$16.613$10.166$1.233$11.169
Other Income--------
Income From Continuous Operations$39.664$73.899$47.362$26.376$16.613$10.166$1.233$11.169
Income From Discontinued Operations--------
Net Income$39.664$73.899$47.362$26.376$16.613$12.058$-7.132$3.993
EBITDA$132.358$95.855$70.37$54.398$34.767$22.763$15.794$10.457
EBIT$77.006$77.67$54.418$41.212$26.143$16.873$11.524$7.092
Basic Shares Outstanding67626059573165
Shares Outstanding686362605952638
Basic EPS$0.59$1.20$0.79$0.45$0.29$0.39$-1.26$0.81
EPS - Earnings Per Share$0.58$1.17$0.77$0.44$0.28$0.21$-1.26$0.25
# 2020 2019 2018 2017 2016 2015
Current Ratio1.956713.584712.952512.788611.816314.1229
Long-term Debt / Capital0.5342-----
Debt/Equity Ratio1.1848-----
Gross Margin61.261963.0858.780559.626157.260354.6047
Operating Margin14.47527.039823.70923.104820.619819.2055
EBIT Margin14.47527.039823.70923.104820.619819.2055
EBITDA Margin24.879733.370730.65930.497327.421825.9098
Pre-Tax Profit Margin8.111926.395122.737822.492620.155217.9432
Net Profit Margin7.455725.72720.634814.787213.103213.7249
Asset Turnover0.20740.56320.62180.6390.57680.5534
Inventory Turnover Ratio---121.64787.463.8112
Receiveable Turnover7.507311.190710.625210.49178.86129.7034
Days Sales In Receivables48.619132.616434.352434.789341.190837.6155
ROE - Return On Equity3.849815.489913.677610.06958.16547.0551
Return On Tangible Equity-3.653618.815218.358213.718312.58899.0042
ROA - Return On Assets1.546414.489612.82979.44927.55846.403
ROI - Return On Investment1.793215.489913.677610.06958.16547.0551
Book Value Per Share14.50087.63995.6934.39953.52452.6294
Operating Cash Flow Per Share-0.25580.46890.55970.31030.1608-2.8978
Free Cash Flow Per Share-0.30120.49620.53230.28980.1534-2.6486